Agranulocytosis, acquired — VA Rating Criteria (38 CFR DC 7702)
The VA rates Agranulocytosis, acquired under 38 CFR 38 CFR § 4.117, Diagnostic Code 7702, from 10% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period. Related conditions in the Hematologic body system share this rating framework.
What are the VA rating criteria for Agranulocytosis, acquired?
Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl
Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period
Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period
Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period
“Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period”
How does the VA rate Hematologic conditions?
Common Questions About Agranulocytosis, acquired VA Ratings
What is the VA disability rating for Agranulocytosis, acquired?
The VA rates Agranulocytosis, acquired under Diagnostic Code 7702 at the following tiers: 10%, 30%, 60%, 100%. The minimum 10% rating requires: Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl. The maximum 100% rating requires: Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period.
What is Diagnostic Code 7702?
Diagnostic Code 7702 is the VA rating identifier for Agranulocytosis, acquired within 38 CFR 38 CFR § 4.117. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for Agranulocytosis, acquired?
The highest schedular rating for Agranulocytosis, acquired under DC 7702 is 100%. This tier requires: Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period. Veterans who cannot secure substantially gainful employment due to Agranulocytosis, acquired alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.
What 38 CFR section governs Agranulocytosis, acquired ratings?
Agranulocytosis, acquired is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7702. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to Agranulocytosis, acquired?
Secondary conditions caused or aggravated by Agranulocytosis, acquired may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for Agranulocytosis, acquired?
Service connection for Agranulocytosis, acquired requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits